Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_assertion type Assertion NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_head.
- NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_assertion wasGeneratedBy ECO_0000203 NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_provenance.
- NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_assertion wasDerivedFrom befree-2016 NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_provenance.
- NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_assertion SIO_000772 9742914 NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_provenance.
- NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_assertion evidence source_evidence_literature NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_provenance.
- NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_assertion description "[Thus, immunotherapy with high-dose bolus IL-2 should be considered as initial therapy for appropriately selected patients with metastatic melanoma and renal cell cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404180.RAm7ZeUeArrXzN0_l-OWhHlR1QgWkxcBvF9NsccqOYZ1g130_provenance.